Skip to main content
Log in

Forum

  • Update
  • Published:
Pharmaceutical Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

Reference

  • Waller P. Getting to grips with the new European Union pharmacovigilance legislation. Pharmacoepidemiol Drug Saf. Epub 2011 Mar 10

    Google Scholar 

References

  1. NHS Confederation. Where next for NHS reform? A discussion paper April 2011. 2011 April 6 [online]. Available from URL: http://www.nhsconfed.org/Publications/Documents/NHS_reform_discussion_paper_0411.pdf [Accessed 2011 Apr 26]

    Google Scholar 

  2. Hawkes N. Health secretary will pause and listen to staff over reform bill. BMJ 2011; 342: d2216

    Article  Google Scholar 

  3. Triggle N. PM seeks to allay fears, but insists change is needed. 2011 April 6 [online]. Available from URL: http://www.bbc.co.uk [Accessed 2011 Apr 26]

    Google Scholar 

Reference

  1. Stremikis K, Schoen C, Fryer A-K. A call for change: The 2011 Commonwealth Fund survey of public views of the U.S. health system. 2011 Apr 11 [online]. Available from URL: http://www.commonwealthfund.org [Accessed 2011 Apr 26]

    Google Scholar 

Reference

  • Houston M. New government is to introduce universal primary care for Ireland. BMJ 2011; 342: d1825

    Article  Google Scholar 

Reference

Reference

Reference

  • Weiss-Smith S, Deshpande G, Chung S, et al. The FDA drug safety surveillance program: adverse event reporting trends. Arch Intern Med 2011; 171 (6): 591–3

    Article  PubMed  Google Scholar 

References

  1. Hawkes N. Value based drug pricing could increase NHS drugs bill. BMJ 2011; 342: d1759

    Article  Google Scholar 

  2. National Institute for Health and Clinical Excellence. NICE responds to government’s plans to introduce value-based pricing. 2011 Mar 21 [online]. Available from URL: http://www.nice.org.uk/newsroom/news/NICERespondsToGovernmentsPlansToIntroduceValueBasedPricing.jsp [Accessed 2011 Apr 26]

    Google Scholar 

Reference

Reference

Reference

Reference

References

  1. Mashta O. Herbal medicines will need to be registered with drug regulator to be sold in UK. BMJ 2011; 342: d1733

    Article  PubMed  Google Scholar 

  2. MHRA. Press release: 100th traditional herbal registration granted [media release]. 2011 Mar 18 [online]. Available from URL: http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON111687 [Accessed 2011 Apr 26]

    Google Scholar 

Reference

Reference

Reference

Reference

Reference

  • Express Scripts. Harnessing patients good intentions can cut 33% of America’s pharmacy-related waste [media release]. 2011 Apr 7 [online]. Available from URL: http://www.express-scripts.com [Accessed 2011 Apr 27]

    Google Scholar 

Reference

  • Coloma PM, Schuemie MJ, Trifiro G, et al. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf 2011; 20 (1): 1–11

    Article  PubMed  Google Scholar 

References

  1. Knezevic MZ, Bivolarevic IC, Peric TS, Jankovic SM. Using Facebook to increase spontaneous reporting of adverse drug reactions. Drug Saf 2011; 34 (4): 351–2

    Article  PubMed  Google Scholar 

  2. Edwards IR, Lindquist M. Social media and networks in pharmacovigilance: boon or bane? Drug Saf 2011 34 (4): 267–71

    Article  PubMed  Google Scholar 

References

  1. European Parliament. The news: migrant upsurge — fake drugs (video presentation). 2011 [online]. Available from URL: http://www.europarl.europa.eu/en/headlines/content/20110211MUN13588 [Accessed 2011 April 27]

    Google Scholar 

  2. Watson R. European Union clamps down on fake drugs. BMJ 2011; 342: d1198

    Article  PubMed  Google Scholar 

Reference

  • Zarocostas J. Patent rules must not hinder access to cheap drugs in poor countries, experts say. BMJ 2011; 342: d1219

    Article  PubMed  Google Scholar 

Reference

  • Michelis KC, Hassouna B, Owlia M, et al. Effect of electronic prescription on attainment of cholesterol goals. Clin Cardiol 2011; 34 (4): 254–60

    Article  PubMed  Google Scholar 

Reference

  • Chambers JD, Neumann PJ. Listening to Provenge — what a costly cancer treatment says about future Medicare policy. New Eng J Med. Epub 2011 Apr 6

    Google Scholar 

Reference

  • Zarocostas J. Poor countries should use flexibility in global trade agreement to improve access to antiretrovirals, says report. BMJ 2011; 342: d1677

    Article  PubMed  Google Scholar 

Reference

  • Hsiao WC. State-based, single-payer health care — a solution for the United States? N Engl J Med 2011; 364 (13): 1188–90

    Article  PubMed  CAS  Google Scholar 

Reference

Reference

  • Mudur G. India’s proposed pact with Europe may choke its generic drug exports, health rights activists fear. BMJ 2011; 342: d1480

    Article  Google Scholar 

References

  1. Schramm TK, Gislason GH, Vaag A, et al. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. Eur Heart J. Epub 2011 Apr 6

    Google Scholar 

  2. Gore MO, McGuire DK. Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments. Eur Heart J. Epub 2011 Apr 6

    Google Scholar 

Reference

Reference

  • Huang CC, Chan WL, Chen YC, et al. Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension. Am J Cardiol 2011; 107 (7): 1028–33

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Forum. Pharm Med 25, 189–198 (2011). https://doi.org/10.1007/BF03256860

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03256860

Navigation